The European Commission’s Scientific Committee on Consumer Safety (SCCS) announced on March 3, 2020, that the April 2020 issue of Regulatory Toxicology and Pharmacology includes “The SCCS guidance on the safety assessment of nanomaterials in cosmetics.” The highlights state that:
- The guidance provides an overview of the key issues and data requirements relating to the safety assessment of nanomaterials;
- The guidance facilitates the applicants and the risk assessors in preparing and assessing safety dossiers on nanomaterials; and
- The guidance is complementary to the SCCS general Notes of Guidance.
The article is available for purchase through the Regulatory Toxicology and Pharmacology website.
As reported in our November 5, 2019, blog item, SCCS published an updated Guidance on the Safety Assessment of Nanomaterials in Cosmetics. The Guidance updates SCCS’s 2012 Guidance (SCCS/1484/12) on the safety assessment of nanomaterials in cosmetic products. It covers the main elements of safety assessment — general considerations (Section 2), material characterization (Section 3), exposure assessment (Section 4), hazard identification and dose-response characterization (Section 5), and risk assessment (Section 6).
[View source.]
